An interventional study of Corneal Cross Linking in Keratoconus, sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Recruiting at 1 site in Mexico. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-07.
Sponsored by Instituto de Oftalmología Fundación Conde de Valenciana · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to document corneal ectasia stability in patients with keratoconus diagnosis treated with personalized cross linking energy. The main questions it aims to answer are:
313 studies on the registry are indexed under Keratoconus; 56 are open to participants now.
This study's planned enrollment of 20 is below the median of 40 across 205 interventional studies indexed under Keratoconus.
Browse Keratoconus studies →Instituto de Oftalmología Fundación Conde de Valenciana is the lead sponsor of 45 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants were treated with personalized energy cross linking according to their thinnest point corneal pachymetry
Procedure: Corneal Cross Linking
Total fluence adapted to thinnest point pachymetry
Keratometry stability
Stability documented by changes in keratometries (measured in diopters) obtained with corneal tomography, as well as uncorrected visual acuity observed in follow up consults
Time frame: Baseline and 6 months
Pachymetry stability
Stability documented by changes in pachymetry (measured in microns) obtained with corneal tomography
Time frame: Baseline and 6 months
Uncorrected visual acuity stability
Stability documented by changes in uncorrected visual acuity (measured in logarithm of the minimum angle of resolution) obtained on physical examiantion
Time frame: Baseline, 72 hours, 1 week, 3 months and 6 months
Corneal endothelium safety
Corneal endothelial cell count obtained by specular microscopy
Time frame: Baseline, 72 hours, 1 week, 3 months and 6 months
Plan to share: No
Started Mar 2023 (actual). Primary completion is estimated for May 2024, 14 months after the start.
Of 59 non-industry interventional studies with no phase under Keratoconus, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's planned 14 months is below that.
Counting every sponsor, half of 68 studies reached it within 34 months; a quarter within 12 and three quarters within 59.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto de Oftalmología Fundación Conde de Valenciana